久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • AZ’ Lynparza cuts risk of breast cancer progression pharmatimes
    June 06, 2017
    AstraZeneca has unveiled new data showing a significant reduction in the risk of death or disease progression in certain patients with breast cancer taking its PARP inhibitor Lynparza.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service